9 of 10
9. Johnson & Johnson
9
- R&D investment: $7.7 billion
- 1-year growth: 1.6%
After a rough few years of recalls and lawsuits, Johnson & Johnson (JNJ) -- which makes everything from baby powder to artificial hips -- has begun to regain some momentum, driven by blockbuster drugs such as Remicade, which is used to treat Crohn's disease and rheumatoid arthritis.
But its woes aren't entirely over. Earlier this month the company paid $2.2 billion to settle charges that it marketed drugs for unapproved uses and paid "kickbacks" to doctors and nursing homes.
- Last updated November 21 2013 01:25 PM ET
